John Gordon
Physician Assistant · Horseheads, NYNPI 1831158351
Payments from drug & device makers
Across 234 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$864
- AstraZeneca$841
- Amgen$490
- Takeda Pharmaceuticals U.S.A., Inc.$340
- Sanofi$334
- Pfizer$203
- plus $1K from 19 others
What the payments were for
- Consulting fees$441%
- Food & beverage$4,05198%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 72 | $864 |
| AstraZeneca | 38 | $841 |
| Amgen(2 entities) | 27 | $490 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $340 |
| Sanofi | 17 | $334 |
| Pfizer | 12 | $203 |
| CSL Behring | 8 | $168 |
| Novartis | 7 | $158 |
| Optinose US, Inc. | 7 | $141 |
| Pharming Healthcare, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| Genentech USA, Inc. | 3 | $67 |
| Biocryst US Sales Co., LLC | 3 | $58 |
| Boehringer Ingelheim | 3 | $50 |
| ADMA Biomanufacturing LLC | 2 | $44 |
| Merck | 2 | $31 |
| Organon | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $21 |
| Alk-abello, Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Grifols USA, LLC | 1 | $16 |
| Octapharma USA, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,129 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $179,012 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 132 | $134,272 |
| Dupixent SyringeDupilumab | 29 | $119,667 |
| Breo ElliptaFluticasone/Vilanterol | 120 | $86,881 |
| XolairOmalizumab | 21 | $62,414 |
| XhanceFluticasone Propionate | 36 | $46,200 |
| Spiriva RespimatTiotropium Bromide | 30 | $28,939 |
| Advair HfaFluticasone Propion/Salmeterol | 38 | $25,633 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $17,063 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 40 | $9,282 |
| Mometasone Furoate | 88 | $9,041 |
| QnaslBeclomethasone Dipropionate | 12 | $8,225 |
| Qvar RedihalerBeclomethasone Dipropionate | 16 | $7,825 |
| Desloratadine | 186 | $7,783 |
| Levocetirizine Dihydrochloride | 401 | $7,246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $864 | $224,846264 claims |
| Optinose US, Inc.Xhance | $141 | $46,20036 claims |
| Boehringer IngelheimSpiriva Respimat | $50 | $28,93930 claims |
| AstraZenecaBreztri Aerosphere | $841 | $17,06311 claims |
| Teva Pharmaceuticals USA, Inc.Qnasl, Qvar Redihaler | $14 | $16,05128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Horseheads
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.